Sabra Health Care REIT Inc. (NASDAQ:SBRA) finished Wednesday with a subtraction of -$0.3 to close at $12.28, a downside of -2.38 percent. An average of 1,333,260 shares of common stock have been traded in the last five days. There was a fall of -$0.03 in the past week, and it reached a new high 19 times over the past 12 months. The last 20 days have seen an average of 2,043,970 shares traded, while the 50-day average volume stands at 2,220,464.
SBRA stock has decreased by -0.73% in the last month. The company shares reached their 1-month lowest point of $12.04 on 12/19/22. With the stock rallying to its 52-week high on 08/15/22, shares of the company touched a low of $11.44 and a high of $16.60 in 52 weeks. It has reached a new high 17 times so far this year and lost -9.31% or -$1.26 in price. In spite of this, the price is down -26.02% from the 52-week high.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
SBRA stock investors should be aware that Sabra Health Care REIT Inc. (SBRA) stock had its last reported insider trading activity 0 days ago on Dec 29.
Sabra Health Care REIT Inc. (SBRA) stock’s beta is 1.25. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.71, the price-to-book (PB) ratio at 0.88.
Further, the company has a long term debt to equity ratio of 0.76 and a total debt to equity ratio of 0.76 for the quarter ending June 29. Its gross profit as reported stood at $201.25 million compared to revenue of $569.54 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Sabra Health Care REIT Inc.’s return on assets was -0.30%.
For the three-month period that ended June 29, Sabra Health Care REIT Inc. had $49.71 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$50.06 million in the quarter, while revenues of $16.81 million were grew 120.42%. The analyst consensus anticipated Sabra Health Care REIT Inc.’s latest quarter earnings to come in at $0.16 per share, but it turned out to be $0.07, a -56.20% surprise. For the quarter, EBITDA amounted to $28.62 million. At the end of the quarter ending June 29, Sabra Health Care REIT Inc.’s stock balance sheet showed total debt was $2.48 billion. Shareholders own equity worth $230.98 million.
From a technical analysis perspective, let’s take a brief look at Sabra Health Care REIT Inc. (SBRA) price momentum. RSI 9-day as of the close on 28 December was 40.67%, suggesting the stock is Neutral, with historical volatility in this time frame at 21.61%.
As of today, SBRA’s price is $12.42 -0.24% or -$0.03 from its 5-day moving average. SBRA is currently trading -4.81% lower than its 20-day SMA and -19.10% lower than its 100-day SMA. However, the stock’s current price level is -3.53% below the SMA50 and -12.29% below the SMA200.
The stochastic %K and %D were 37.69% and 38.96%, respectively, and the average true range (ATR) was 0.34. With the 14-day stochastic at 22.43% and the average true range at 0.36, the RSI (14) stands at 43.21%. The stock has reached 0.04 on the 9-day MACD Oscillator while the 14-day reading was at -0.07.
JMP Securities downgraded Sabra Health Care REIT Inc. (NASDAQ: SBRA) to a a Mkt perform rating in its most recent analyst report. Previously, the stock was rated as a Mkt outperform. The consensus rating for Sabra Health Care REIT Inc. (SBRA) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SBRA, while 9 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is SBRA’s price target for the next 12 months?
Analysts predict a range of price targets between $12.00 and $18.00, with a median target of $14.00. Taking a look at these predictions, the average price target given by analysts for Sabra Health Care REIT Inc. (SBRA) stock is $14.38.